Verastem Oncology
VSTM
#6927
Rank
NZ$1.29 B
Marketcap
NZ$14.28
Share price
3.90%
Change (1 day)
-3.15%
Change (1 year)

Earnings for Verastem Oncology (VSTM)

Earnings in 2026 (TTM): -NZ$0.36 Billion

According to Verastem Oncology 's latest financial reports the company's current earnings are NZ$87.52 Million. In 2025 the company made an earning of -NZ$0.38 Billion a decrease over its 2024 earnings that were of -NZ$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verastem Oncology from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.36 Billion-6.36%
2025 -NZ$0.38 Billion60.57%
2024 -NZ$0.24 Billion49.31%
2023 -NZ$0.16 Billion18.36%
2022 -NZ$0.14 Billion3.67%
2021 -NZ$0.13 Billion5.43%
2020 -NZ$0.13 Billion-54.74%
2019 -NZ$0.27 Billion105.99%
2018 -NZ$0.13 Billion6.83%
2017 -NZ$0.13 Billion86.06%
2016 -NZ$65.04 Million-37.03%
2015 -NZ$0.11 Billion8.43%
2014 -NZ$95.24 Million29.52%
2013 -NZ$73.53 Million28.6%
2012 -NZ$57.18 Million133.9%
2011 -NZ$24.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.32 B-3,521.31%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.60 B-823.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$14.07 B-4,007.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-NZ$15.08 Million-95.82%๐Ÿ‡บ๐Ÿ‡ธ USA